Dennis Matheis - 12 Aug 2024 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Reporting relationship: Director
Issuer ticker: DRIO
Reported as of: 12 Aug 2024
Net transaction value: +$100,000
SEC form: 4
Accepted by SEC: 28 Jul 2026, 17:27:53 UTC
Prior SEC filing: 09 May 2024
Next SEC filing: 21 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Dennis Matheis

Key filing fact

Dennis Matheis filed Form 4 for DarioHealth Corp. (DRIO) on 28 Jul 2026.

Key facts

This page summarizes Dennis Matheis's Form 4 filing for DarioHealth Corp. (DRIO).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 Jul 2026, 17:27.

Change

Previous filing in this sequence was filed on 09 May 2024.
Current net transaction value: +$100,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001817012 Primary reporting owner

Matheis Dennis

Relationship: Director
Address: 322 W 57TH STREET, #33B, NEW YORK
Signature: /s/ Dennis Matheis
Signature date: 28 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DRIO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +965
Change %: +3.5%
Price: $19.10^*
Shares after: 28,596
Date: 12 Aug 2024
Ownership: Direct
Footnotes: F1, F2

DRIO transaction

Common Stock

Purchase

Transaction value: $100,000
Shares: +14,430
Change %: +50%
Price: $6.93
Shares after: 43,026
Date: 23 Jul 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DRIO transaction Derivative

Series B-2 Preferred Stock

Conversion of derivative security

Transaction value
Shares: -50
Change %: -100%
Price: $1000.00^*
Shares after: 0
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 965
Exercise price: $1000.00

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.

Footnote F2

The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion.

Footnote F3

The reported shares were acquired pursuant to a Securities Purchase Agreement with the issuer, dated July 22, 2026, at a purchase price of $6.93 per share.